Tweed, CD;    Dawson, R;    Burger, DA;    Conradie, A;    Crook, AM;    Mendel, CM;    Conradie, F;                                                     ... Spigelman, M; + view all <#>        Tweed, CD;  Dawson, R;  Burger, DA;  Conradie, A;  Crook, AM;  Mendel, CM;  Conradie, F;  Diacon, AH;  Ntinginya, NE;  Everitt, DE;  Haraka, F;  Li, M;  Van Niekerk, CH;  Okwera, A;  Rassool, MS;  Reither, K;  Sebe, MA;  Staples, S;  Variava, E;  Spigelman, M;   - view fewer <#>    (2019)    Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial.                   The Lancet Respiratory Medicine , 7  (12)   pp. 1048-1058.    10.1016/S2213-2600(19)30366-2 <https://doi.org/10.1016/S2213-2600%2819%2930366-2>.       Green open access